PulseAugur
EN
LIVE 12:35:51
中文(ZH) 分子之心获逾亿美元融资，多方资本押注AI生物“产业新基建”

AI Protein Design Firm MoleculeMind Secures Over $100M in Series A Funding

By PulseAugur Editorial · [1 sources] ·

MoleculeMind, an AI protein design platform, has secured over $100 million in Series A funding. The investment, led by Blue Horizon Capital and Pudong Venture Capital, signals a shift in the AI for Science sector towards industrial-scale applications and commercial viability. The company leverages its proprietary AI operating system, MoleculeOS, and its foundational model, NewOrigin, to move beyond basic structure prediction into programmable bioengineering, demonstrating significant advancements in drug discovery and industrial enzyme modification. AI

IMPACT This funding round signifies a major investment in AI for Science, potentially accelerating the development and commercialization of AI-driven solutions in drug discovery and bioengineering.

RANK_REASON Significant funding round for an AI company in the AI for Science sector. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 雷峰网 (Leiphone) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI Protein Design Firm MoleculeMind Secures Over $100M in Series A Funding

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant funding round for an AI company in the AI for Science sector. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, model release
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
102 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 雷峰网 (Leiphone) TIER_1 中文(ZH) ·

    Molecular Heart receives over $100 million in financing, with multiple capital sources betting on AI biology as "new industrial infrastructure"

    <span>雷峰网获悉，近日，AI蛋白质设计平台公司分子之心（MoleculeMind）完成A轮系列融资，累计融资金额逾亿美元。</span><p style="text-align: justify; margin-top: 7.8pt; margin-bottom: 7.8pt;"><span>本轮融资由蓝桥资本、浦东创投、中粮新兴产业基金、东方富海、复星创富、国方创投、赛分科技、英飞尼迪、财鑫资本、正鼎等机构参与投资，凯赛生物、芯航资本等老股东亦继续追加投资。多元化的投资方阵容，充分体现了财务投资机构、产业资本以及战略引导资本对分子之心的深度共识与…

RELATED ENTITIES

RELATED TOPICS